ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Liver Stem Cell Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-18Y17499
Home | Market Reports | Health| Health Foundations & Medical Research
Global Liver Stem Cell Therapy Market Research Report 2024
BUY CHAPTERS

Global Liver Stem Cell Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-18Y17499
Report
October 2025
Pages:121
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
PHARMICELL
StemCell Technologies
Promethera Biosciences
Adverum Biotechnologies
Cellaïon
Goliver Therapeutics
Morphocell Technologies
Stimuliver

Liver Stem Cell Therapy Market

The global Liver Stem Cell Therapy market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Preclinical accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Liver Stem Cell Therapy leading manufacturers including Pharmicell, Cellaïon, Goliver Therapeutics, Morphocell Technologies, STEMCELL Technologies, Promethera Biosciences, Adverum Biotechnologies, Stimuliver, etc., dominate supply; the top five capture approximately % of global revenue, with Pharmicell leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Liver Stem Cell Therapy market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Liver Stem Cell Therapy Market Report

Report Metric Details
Report Name Liver Stem Cell Therapy Market
Segment by Type
  • Autologous
  • Allogeneic
Segment by Application
  • Preclinical
  • Clinical Phase 1,2
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pharmicell, Cellaïon, Goliver Therapeutics, Morphocell Technologies, STEMCELL Technologies, Promethera Biosciences, Adverum Biotechnologies, Stimuliver
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Liver Stem Cell Therapy study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Liver Stem Cell Therapy Market report?

Ans: The main players in the Liver Stem Cell Therapy Market are Pharmicell, Cellaïon, Goliver Therapeutics, Morphocell Technologies, STEMCELL Technologies, Promethera Biosciences, Adverum Biotechnologies, Stimuliver

What are the Application segmentation covered in the Liver Stem Cell Therapy Market report?

Ans: The Applications covered in the Liver Stem Cell Therapy Market report are Preclinical, Clinical Phase 1,2

What are the Type segmentation covered in the Liver Stem Cell Therapy Market report?

Ans: The Types covered in the Liver Stem Cell Therapy Market report are Autologous, Allogeneic

1 Study Coverage
1.1 Introduction to Liver Stem Cell Therapy: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Liver Stem Cell Therapy Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Autologous
1.2.3 Allogeneic
1.3 Market Segmentation by Application
1.3.1 Global Liver Stem Cell Therapy Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Preclinical
1.3.3 Clinical Phase 1,2
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Liver Stem Cell Therapy Revenue Estimates and Forecasts 2020-2031
2.2 Global Liver Stem Cell Therapy Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Liver Stem Cell Therapy Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Liver Stem Cell Therapy Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Autologous Market Size by Players
3.3.2 Allogeneic Market Size by Players
3.4 Global Liver Stem Cell Therapy Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Liver Stem Cell Therapy Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Liver Stem Cell Therapy Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Liver Stem Cell Therapy Market Size by Type (2020-2031)
6.4 North America Liver Stem Cell Therapy Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Liver Stem Cell Therapy Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Liver Stem Cell Therapy Market Size by Type (2020-2031)
7.4 Europe Liver Stem Cell Therapy Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Liver Stem Cell Therapy Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Liver Stem Cell Therapy Market Size by Type (2020-2031)
8.4 Asia-Pacific Liver Stem Cell Therapy Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Liver Stem Cell Therapy Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Liver Stem Cell Therapy Market Size by Type (2020-2031)
9.4 Central and South America Liver Stem Cell Therapy Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Liver Stem Cell Therapy Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Liver Stem Cell Therapy Market Size by Type (2020-2031)
10.4 Middle East and Africa Liver Stem Cell Therapy Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Liver Stem Cell Therapy Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Pharmicell
11.1.1 Pharmicell Corporation Information
11.1.2 Pharmicell Business Overview
11.1.3 Pharmicell Liver Stem Cell Therapy Product Features and Attributes
11.1.4 Pharmicell Liver Stem Cell Therapy Revenue and Gross Margin (2020-2025)
11.1.5 Pharmicell Liver Stem Cell Therapy Revenue by Product in 2024
11.1.6 Pharmicell Liver Stem Cell Therapy Revenue by Application in 2024
11.1.7 Pharmicell Liver Stem Cell Therapy Revenue by Geographic Area in 2024
11.1.8 Pharmicell Liver Stem Cell Therapy SWOT Analysis
11.1.9 Pharmicell Recent Developments
11.2 Cellaïon
11.2.1 Cellaïon Corporation Information
11.2.2 Cellaïon Business Overview
11.2.3 Cellaïon Liver Stem Cell Therapy Product Features and Attributes
11.2.4 Cellaïon Liver Stem Cell Therapy Revenue and Gross Margin (2020-2025)
11.2.5 Cellaïon Liver Stem Cell Therapy Revenue by Product in 2024
11.2.6 Cellaïon Liver Stem Cell Therapy Revenue by Application in 2024
11.2.7 Cellaïon Liver Stem Cell Therapy Revenue by Geographic Area in 2024
11.2.8 Cellaïon Liver Stem Cell Therapy SWOT Analysis
11.2.9 Cellaïon Recent Developments
11.3 Goliver Therapeutics
11.3.1 Goliver Therapeutics Corporation Information
11.3.2 Goliver Therapeutics Business Overview
11.3.3 Goliver Therapeutics Liver Stem Cell Therapy Product Features and Attributes
11.3.4 Goliver Therapeutics Liver Stem Cell Therapy Revenue and Gross Margin (2020-2025)
11.3.5 Goliver Therapeutics Liver Stem Cell Therapy Revenue by Product in 2024
11.3.6 Goliver Therapeutics Liver Stem Cell Therapy Revenue by Application in 2024
11.3.7 Goliver Therapeutics Liver Stem Cell Therapy Revenue by Geographic Area in 2024
11.3.8 Goliver Therapeutics Liver Stem Cell Therapy SWOT Analysis
11.3.9 Goliver Therapeutics Recent Developments
11.4 Morphocell Technologies
11.4.1 Morphocell Technologies Corporation Information
11.4.2 Morphocell Technologies Business Overview
11.4.3 Morphocell Technologies Liver Stem Cell Therapy Product Features and Attributes
11.4.4 Morphocell Technologies Liver Stem Cell Therapy Revenue and Gross Margin (2020-2025)
11.4.5 Morphocell Technologies Liver Stem Cell Therapy Revenue by Product in 2024
11.4.6 Morphocell Technologies Liver Stem Cell Therapy Revenue by Application in 2024
11.4.7 Morphocell Technologies Liver Stem Cell Therapy Revenue by Geographic Area in 2024
11.4.8 Morphocell Technologies Liver Stem Cell Therapy SWOT Analysis
11.4.9 Morphocell Technologies Recent Developments
11.5 STEMCELL Technologies
11.5.1 STEMCELL Technologies Corporation Information
11.5.2 STEMCELL Technologies Business Overview
11.5.3 STEMCELL Technologies Liver Stem Cell Therapy Product Features and Attributes
11.5.4 STEMCELL Technologies Liver Stem Cell Therapy Revenue and Gross Margin (2020-2025)
11.5.5 STEMCELL Technologies Liver Stem Cell Therapy Revenue by Product in 2024
11.5.6 STEMCELL Technologies Liver Stem Cell Therapy Revenue by Application in 2024
11.5.7 STEMCELL Technologies Liver Stem Cell Therapy Revenue by Geographic Area in 2024
11.5.8 STEMCELL Technologies Liver Stem Cell Therapy SWOT Analysis
11.5.9 STEMCELL Technologies Recent Developments
11.6 Promethera Biosciences
11.6.1 Promethera Biosciences Corporation Information
11.6.2 Promethera Biosciences Business Overview
11.6.3 Promethera Biosciences Liver Stem Cell Therapy Product Features and Attributes
11.6.4 Promethera Biosciences Liver Stem Cell Therapy Revenue and Gross Margin (2020-2025)
11.6.5 Promethera Biosciences Recent Developments
11.7 Adverum Biotechnologies
11.7.1 Adverum Biotechnologies Corporation Information
11.7.2 Adverum Biotechnologies Business Overview
11.7.3 Adverum Biotechnologies Liver Stem Cell Therapy Product Features and Attributes
11.7.4 Adverum Biotechnologies Liver Stem Cell Therapy Revenue and Gross Margin (2020-2025)
11.7.5 Adverum Biotechnologies Recent Developments
11.8 Stimuliver
11.8.1 Stimuliver Corporation Information
11.8.2 Stimuliver Business Overview
11.8.3 Stimuliver Liver Stem Cell Therapy Product Features and Attributes
11.8.4 Stimuliver Liver Stem Cell Therapy Revenue and Gross Margin (2020-2025)
11.8.5 Stimuliver Recent Developments
12 Liver Stem Cell TherapyIndustry Chain Analysis
12.1 Liver Stem Cell Therapy Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Liver Stem Cell Therapy Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Liver Stem Cell Therapy Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
PHARMICELL
StemCell Technologies
Promethera Biosciences
Adverum Biotechnologies
Cellaïon
Goliver Therapeutics
Morphocell Technologies
Stimuliver
List of Tables
 Table 1. Global Liver Stem Cell Therapy Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Liver Stem Cell Therapy Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Liver Stem Cell Therapy Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Liver Stem Cell Therapy Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Liver Stem Cell Therapy Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Liver Stem Cell Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Liver Stem Cell Therapy Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Liver Stem Cell Therapy by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Stem Cell Therapy as of 2024)
 Table 11. Global Liver Stem Cell Therapy Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Liver Stem Cell Therapy Companies Headquarters
 Table 13. Global Liver Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Liver Stem Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Liver Stem Cell Therapy Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Liver Stem Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Liver Stem Cell Therapy Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Liver Stem Cell Therapy High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Liver Stem Cell Therapy Growth Accelerators and Market Barriers
 Table 25. North America Liver Stem Cell Therapy Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Liver Stem Cell Therapy Growth Accelerators and Market Barriers
 Table 27. Europe Liver Stem Cell Therapy Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Liver Stem Cell Therapy Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Liver Stem Cell Therapy Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Liver Stem Cell Therapy Investment Opportunities and Key Challenges
 Table 31. Central and South America Liver Stem Cell Therapy Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Liver Stem Cell Therapy Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Liver Stem Cell Therapy Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Pharmicell Corporation Information
 Table 35. Pharmicell Description and Major Businesses
 Table 36. Pharmicell Product Features and Attributes
 Table 37. Pharmicell Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Pharmicell Revenue Proportion by Product in 2024
 Table 39. Pharmicell Revenue Proportion by Application in 2024
 Table 40. Pharmicell Revenue Proportion by Geographic Area in 2024
 Table 41. Pharmicell Liver Stem Cell Therapy SWOT Analysis
 Table 42. Pharmicell Recent Developments
 Table 43. Cellaïon Corporation Information
 Table 44. Cellaïon Description and Major Businesses
 Table 45. Cellaïon Product Features and Attributes
 Table 46. Cellaïon Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Cellaïon Revenue Proportion by Product in 2024
 Table 48. Cellaïon Revenue Proportion by Application in 2024
 Table 49. Cellaïon Revenue Proportion by Geographic Area in 2024
 Table 50. Cellaïon Liver Stem Cell Therapy SWOT Analysis
 Table 51. Cellaïon Recent Developments
 Table 52. Goliver Therapeutics Corporation Information
 Table 53. Goliver Therapeutics Description and Major Businesses
 Table 54. Goliver Therapeutics Product Features and Attributes
 Table 55. Goliver Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Goliver Therapeutics Revenue Proportion by Product in 2024
 Table 57. Goliver Therapeutics Revenue Proportion by Application in 2024
 Table 58. Goliver Therapeutics Revenue Proportion by Geographic Area in 2024
 Table 59. Goliver Therapeutics Liver Stem Cell Therapy SWOT Analysis
 Table 60. Goliver Therapeutics Recent Developments
 Table 61. Morphocell Technologies Corporation Information
 Table 62. Morphocell Technologies Description and Major Businesses
 Table 63. Morphocell Technologies Product Features and Attributes
 Table 64. Morphocell Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Morphocell Technologies Revenue Proportion by Product in 2024
 Table 66. Morphocell Technologies Revenue Proportion by Application in 2024
 Table 67. Morphocell Technologies Revenue Proportion by Geographic Area in 2024
 Table 68. Morphocell Technologies Liver Stem Cell Therapy SWOT Analysis
 Table 69. Morphocell Technologies Recent Developments
 Table 70. STEMCELL Technologies Corporation Information
 Table 71. STEMCELL Technologies Description and Major Businesses
 Table 72. STEMCELL Technologies Product Features and Attributes
 Table 73. STEMCELL Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. STEMCELL Technologies Revenue Proportion by Product in 2024
 Table 75. STEMCELL Technologies Revenue Proportion by Application in 2024
 Table 76. STEMCELL Technologies Revenue Proportion by Geographic Area in 2024
 Table 77. STEMCELL Technologies Liver Stem Cell Therapy SWOT Analysis
 Table 78. STEMCELL Technologies Recent Developments
 Table 79. Promethera Biosciences Corporation Information
 Table 80. Promethera Biosciences Description and Major Businesses
 Table 81. Promethera Biosciences Product Features and Attributes
 Table 82. Promethera Biosciences Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Promethera Biosciences Recent Developments
 Table 84. Adverum Biotechnologies Corporation Information
 Table 85. Adverum Biotechnologies Description and Major Businesses
 Table 86. Adverum Biotechnologies Product Features and Attributes
 Table 87. Adverum Biotechnologies Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Adverum Biotechnologies Recent Developments
 Table 89. Stimuliver Corporation Information
 Table 90. Stimuliver Description and Major Businesses
 Table 91. Stimuliver Product Features and Attributes
 Table 92. Stimuliver Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Stimuliver Recent Developments
 Table 94. Raw Materials Key Suppliers
 Table 95. Distributors List
 Table 96. Market Trends and Market Evolution
 Table 97. Market Drivers and Opportunities
 Table 98. Market Challenges, Risks, and Restraints
 Table 99. Research Programs/Design for This Report
 Table 100. Key Data Information from Secondary Sources
 Table 101. Key Data Information from Primary Sources


List of Figures
 Figure 1. Liver Stem Cell Therapy Product Picture
 Figure 2. Global Liver Stem Cell Therapy Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Autologous Product Picture
 Figure 4. Allogeneic Product Picture
 Figure 5. Global Liver Stem Cell Therapy Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Preclinical
 Figure 7. Clinical Phase 1,2
 Figure 8. Liver Stem Cell Therapy Report Years Considered
 Figure 9. Global Liver Stem Cell Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global Liver Stem Cell Therapy Revenue (2020-2031) & (US$ Million)
 Figure 11. Global Liver Stem Cell Therapy Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global Liver Stem Cell Therapy Revenue Market Share by Region (2020-2031)
 Figure 13. Global Liver Stem Cell Therapy Revenue Market Share Ranking (2024)
 Figure 14. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 15. Autologous Revenue Market Share by Player in 2024
 Figure 16. Allogeneic Revenue Market Share by Player in 2024
 Figure 17. Global Liver Stem Cell Therapy Revenue Market Share by Type (2020-2031)
 Figure 18. Global Liver Stem Cell Therapy Revenue Market Share by Application (2020-2031)
 Figure 19. North America Liver Stem Cell Therapy Revenue YoY (2020-2031) & (US$ Million)
 Figure 20. North America Top 5 Players Liver Stem Cell Therapy Revenue (US$ Million) in 2024
 Figure 21. North America Liver Stem Cell Therapy Revenue (US$ Million) by Type (2020 - 2031)
 Figure 22. North America Liver Stem Cell Therapy Revenue (US$ Million) by Application (2020-2031)
 Figure 23. US Liver Stem Cell Therapy Revenue (2020-2031) & (US$ Million)
 Figure 24. Canada Liver Stem Cell Therapy Revenue (2020-2031) & (US$ Million)
 Figure 25. Mexico Liver Stem Cell Therapy Revenue (2020-2031) & (US$ Million)
 Figure 26. Europe Liver Stem Cell Therapy Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. Europe Top 5 Players Liver Stem Cell Therapy Revenue (US$ Million) in 2024
 Figure 28. Europe Liver Stem Cell Therapy Revenue (US$ Million) by Type (2020-2031)
 Figure 29. Europe Liver Stem Cell Therapy Revenue (US$ Million) by Application (2020-2031)
 Figure 30. Germany Liver Stem Cell Therapy Revenue (2020-2031) & (US$ Million)
 Figure 31. France Liver Stem Cell Therapy Revenue (2020-2031) & (US$ Million)
 Figure 32. U.K. Liver Stem Cell Therapy Revenue (2020-2031) & (US$ Million)
 Figure 33. Italy Liver Stem Cell Therapy Revenue (2020-2031) & (US$ Million)
 Figure 34. Russia Liver Stem Cell Therapy Revenue (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Liver Stem Cell Therapy Revenue YoY (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Top 8 Players Liver Stem Cell Therapy Revenue (US$ Million) in 2024
 Figure 37. Asia-Pacific Liver Stem Cell Therapy Revenue (US$ Million) by Type (2020-2031)
 Figure 38. Asia-Pacific Liver Stem Cell Therapy Revenue (US$ Million) by Application (2020-2031)
 Figure 39. Indonesia Liver Stem Cell Therapy Revenue (2020-2031) & (US$ Million)
 Figure 40. Japan Liver Stem Cell Therapy Revenue (2020-2031) & (US$ Million)
 Figure 41. South Korea Liver Stem Cell Therapy Revenue (2020-2031) & (US$ Million)
 Figure 42. Australia Liver Stem Cell Therapy Revenue (2020-2031) & (US$ Million)
 Figure 43. India Liver Stem Cell Therapy Revenue (2020-2031) & (US$ Million)
 Figure 44. Indonesia Liver Stem Cell Therapy Revenue (2020-2031) & (US$ Million)
 Figure 45. Vietnam Liver Stem Cell Therapy Revenue (2020-2031) & (US$ Million)
 Figure 46. Malaysia Liver Stem Cell Therapy Revenue (2020-2031) & (US$ Million)
 Figure 47. Philippines Liver Stem Cell Therapy Revenue (2020-2031) & (US$ Million)
 Figure 48. Singapore Liver Stem Cell Therapy Revenue (2020-2031) & (US$ Million)
 Figure 49. Central and South America Liver Stem Cell Therapy Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Central and South America Top 5 Players Liver Stem Cell Therapy Revenue (US$ Million) in 2024
 Figure 51. Central and South America Liver Stem Cell Therapy Revenue (US$ Million) by Type (2020-2031)
 Figure 52. Central and South America Liver Stem Cell Therapy Revenue (US$ Million) by Application (2020-2031)
 Figure 53. Brazil Liver Stem Cell Therapy Revenue (2020-2025) & (US$ Million)
 Figure 54. Argentina Liver Stem Cell Therapy Revenue (2020-2025) & (US$ Million)
 Figure 55. Middle East and Africa Liver Stem Cell Therapy Revenue YoY (2020-2031) & (US$ Million)
 Figure 56. Middle East and Africa Top 5 Players Liver Stem Cell Therapy Revenue (US$ Million) in 2024
 Figure 57. South America Liver Stem Cell Therapy Revenue (US$ Million) by Type (2020-2031)
 Figure 58. Middle East and Africa Liver Stem Cell Therapy Revenue (US$ Million) by Application (2020-2031)
 Figure 59. GCC Countries Liver Stem Cell Therapy Revenue (2020-2025) & (US$ Million)
 Figure 60. Israel Liver Stem Cell Therapy Revenue (2020-2025) & (US$ Million)
 Figure 61. Egypt Liver Stem Cell Therapy Revenue (2020-2025) & (US$ Million)
 Figure 62. South Africa Liver Stem Cell Therapy Revenue (2020-2025) & (US$ Million)
 Figure 63. Liver Stem Cell Therapy Industry Chain Mapping
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Cardiac Disease Stem Cell Therapy Market Research Report 2024
Global Plant Stem Cell Market Research Report 2025
Global Stem Cell Source Market Research Report 2024
Global Disc Disease Stem Cell Therapy Market Research Report 2024
Global Mouse Hepatocytes Market Research Report 2024
Global Stem Cell Cytokines Market Research Report 2024
Global Neuronal Regeneration Stem Cell Therapy Market Research Report 2024
Global Stem Cell Hair Transplant Market Research Report 2024
Plant Based Stem Cell Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Treatment of Alcoholic Cirrhosis Market Research Report 2024
Global Stem Cell Equipment Market Research Report 2024
Global Cell Based Regenerative Therapy Market Research Report 2024
Global Epithelial Stem Cells Market Research Report 2025
Global Stem Cell Storage Services Market Research Report 2024
Stem Cell Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cell Therapy Manufacturing Market Research Report 2025
Cancer Stem Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Adult Stem Cell Storage Market Research Report 2025
Global Advanced Liver Cancer Treatment Drugs Market Research Report 2024
Global Tissue Regenerative Therapy Market Research Report 2024

RELATED REPORTS

Global Cord Blood Processing System Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-36T16872
Tue Nov 11 00:00:00 UTC 2025

Add to Cart

Global Emotional Health Monitoring Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-6J17145
Mon Nov 10 00:00:00 UTC 2025

Add to Cart

Global Endpoint Adjudication Service Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-17S17057
Mon Nov 10 00:00:00 UTC 2025

Add to Cart

Global Medical Speech Recognition System Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-34I16915
Wed Nov 05 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions